SlideShare a Scribd company logo
Editorial Slides - VP Watch, September 5th
, 2001, Volume 1, Issue 25
Is coated stent THE answer?
In-Stent Restenosis = Neointimal Hyperplasia
The long-term clinical efficacy of intracoronary stenting is
limited by restenosis which, occurs in 15-30 % of patients. In-
stent restenosis is due solely to neointimal hyperplasia.
Shape and chemical biocompatibility of stent, and the extent of
inflammatory response to stenting are among major factors
predicting restenosis. Intravascular radiation has shown
significant benefit however the cost, repated interventions,
radiation safety, short and long term adverse effect all remain
unresolved issues.
Experimental data suggest that in-situ immunosuppressant and
inhibitors of cell cycle progression may be an effective strategy
to prevent restenosis.
Effects of drug-coated stents on arterial repair
Suzuki et al., Circulation. 2001;104:1188
Endothelium
SM
C
Fibrin
0
1/2
1
1 1/2
2
2 1/2
3
Repairscore
Control
Dexametasone
Sirolimus
SRL+DEX
From VP Watch this week:
High-power
photomicrographs
of bare metal (B) and
SRL-coated (C) stents
As highlighted in VP Watch this week, Suzuki, Carter, et al.
determined that stents coated with a nonerodable polymer
matrix containing 185 µg SRL compared with a bare metal
stent reduces restenosis by 50% through inhibiting cellular
proliferation. The dose-response effects for this SRL-eluting
stent are incompletely characterized but, they indicated a dose-
dependent reduction in intimal hyperplasia with 60 µg to 200
µg SRL–coated stents in the rabbit model.
Circulation 2001;104:1188
 Also Suzuki et al. also showed that stent-based delivery of
dexamethasone (DEX) alone is insufficient to inhibit neointimal
formation. They did not observed any synergism in combination
of dexamethasonwith SRL.
Circulation 2001;104:1188
 It was shown years go that intraperitoneal administration of SRL, a potent
immunosuppressive agent, resulted in a dose-dependent inhibition of arterial
intimal thickening caused by either chronic alloimmune or mechanical injury
in a rat model. (Gregory CR, Huie P, Billingham ME, et al., Transplantation.
1993; 55: 1409–1418)
Other studies about the effect of Sirolimus on restenosis:
 Other studies also show that SRL inhibits the proliferation of vascular SMC
in human and rat in vitro by blocking the G1
/S transition. (Poon M et al., J
Clin Invest. 1996; 98: 2277–2283 and Marx SO et al., Circ Res. 1995; 76: 412–
417)
 Study of Gallo et al. indicates that systemic SRL therapy significantly
reduces the proliferative response after coronary angioplasty in the porcine
model. (Circulation. 1999; 99: 2164–2170)
Latest on Sirulimon restenosis clinical trial:
The RAVEL study this week
reported “zero” restenosis at 210
days.
Congress of European Society of Cardiology
Stockholm Sep 1-5th
Conclusion:
 Stent-based delivery of Sirolimus via a nonerodable
polymer matrix is feasible and effectively reduces restenosis.
Adding dexamethasone did not offer additional benefit.
If RAVEL holds true for 5 years, the immunosuppressant
RAPAMUNE® (Sirolimus) coated stents becomes the standard
therapy for coronary revascularization.
Questions:
Feel free to send your response to: 
Discussion-Group@VulnerablePlaque.org
 Knowing atherosclerosis as a diffuse disease, do you think that
stenting vulnerable plaques with coated stents can be the
treatment of choice besides statins?
If the coated stent reduces restenosis by 90%, will you stent
every vulnerable plaque? What if you find 3, 4, 5 or more
vulnerable plaques in one patient?

More Related Content

What's hot

Bioabsorbable Drug-Eluting Cardiac Stent Analysis
Bioabsorbable Drug-Eluting Cardiac Stent AnalysisBioabsorbable Drug-Eluting Cardiac Stent Analysis
Bioabsorbable Drug-Eluting Cardiac Stent Analysis
University of Toronto
 
Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...
Scleroderma & Raynaud's UK (SRUK)
 
Ojchd.000538
Ojchd.000538Ojchd.000538
Coronary Stent thrombosis,comparisons between stents.Bioreabsorbable vascular...
Coronary Stent thrombosis,comparisons between stents.Bioreabsorbable vascular...Coronary Stent thrombosis,comparisons between stents.Bioreabsorbable vascular...
Coronary Stent thrombosis,comparisons between stents.Bioreabsorbable vascular...
Dr.Hasan Mahmud
 
Problem associated with drug eluting stent
Problem associated with drug eluting stentProblem associated with drug eluting stent
Problem associated with drug eluting stent
PRAVEEN GUPTA
 
In stent retenosis treatment
In stent retenosis treatmentIn stent retenosis treatment
In stent retenosis treatment
Nilesh Tawade
 
osteoporosis
osteoporosisosteoporosis
osteoporosis
sahibzadaAdnan
 
2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster
Chi Y. Lo, Ph.D.
 
Instent restenosis
Instent restenosis Instent restenosis
Instent restenosis
Sayee Venkatesh
 
Goldschmidt1
Goldschmidt1Goldschmidt1
Vascular_Poster
Vascular_PosterVascular_Poster
Vascular_Poster
Elman Amador
 
Editorialslides v2n9
Editorialslides v2n9Editorialslides v2n9
Positive remodeling for ralph
Positive remodeling for ralphPositive remodeling for ralph
Aging and the telomere connection dr. Jerry w. Shay - april 2012
Aging and the telomere connection   dr. Jerry w. Shay - april 2012Aging and the telomere connection   dr. Jerry w. Shay - april 2012
Aging and the telomere connection dr. Jerry w. Shay - april 2012
Life Length
 
Prediction of Restenosis After PCI with Contemporary Drug-Eluting Stents
Prediction of Restenosis After PCI with Contemporary Drug-Eluting StentsPrediction of Restenosis After PCI with Contemporary Drug-Eluting Stents
Prediction of Restenosis After PCI with Contemporary Drug-Eluting Stents
Sociedad Latinoamericana de Cardiología Intervencionista
 
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse ModelVascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Scintica Instrumentation
 
Genetic Insights Into Multiple Sclerosis Pathogenesis
Genetic Insights Into Multiple Sclerosis PathogenesisGenetic Insights Into Multiple Sclerosis Pathogenesis
Genetic Insights Into Multiple Sclerosis Pathogenesis
Aaron Sparshott
 
Newer trends in interventional cardiology
Newer trends in interventional cardiologyNewer trends in interventional cardiology
Newer trends in interventional cardiology
Suraj Bhorkar
 

What's hot (18)

Bioabsorbable Drug-Eluting Cardiac Stent Analysis
Bioabsorbable Drug-Eluting Cardiac Stent AnalysisBioabsorbable Drug-Eluting Cardiac Stent Analysis
Bioabsorbable Drug-Eluting Cardiac Stent Analysis
 
Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...Horizon scanning: stem cell transplantation and future potential therapeutic ...
Horizon scanning: stem cell transplantation and future potential therapeutic ...
 
Ojchd.000538
Ojchd.000538Ojchd.000538
Ojchd.000538
 
Coronary Stent thrombosis,comparisons between stents.Bioreabsorbable vascular...
Coronary Stent thrombosis,comparisons between stents.Bioreabsorbable vascular...Coronary Stent thrombosis,comparisons between stents.Bioreabsorbable vascular...
Coronary Stent thrombosis,comparisons between stents.Bioreabsorbable vascular...
 
Problem associated with drug eluting stent
Problem associated with drug eluting stentProblem associated with drug eluting stent
Problem associated with drug eluting stent
 
In stent retenosis treatment
In stent retenosis treatmentIn stent retenosis treatment
In stent retenosis treatment
 
osteoporosis
osteoporosisosteoporosis
osteoporosis
 
2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster
 
Instent restenosis
Instent restenosis Instent restenosis
Instent restenosis
 
Goldschmidt1
Goldschmidt1Goldschmidt1
Goldschmidt1
 
Vascular_Poster
Vascular_PosterVascular_Poster
Vascular_Poster
 
Editorialslides v2n9
Editorialslides v2n9Editorialslides v2n9
Editorialslides v2n9
 
Positive remodeling for ralph
Positive remodeling for ralphPositive remodeling for ralph
Positive remodeling for ralph
 
Aging and the telomere connection dr. Jerry w. Shay - april 2012
Aging and the telomere connection   dr. Jerry w. Shay - april 2012Aging and the telomere connection   dr. Jerry w. Shay - april 2012
Aging and the telomere connection dr. Jerry w. Shay - april 2012
 
Prediction of Restenosis After PCI with Contemporary Drug-Eluting Stents
Prediction of Restenosis After PCI with Contemporary Drug-Eluting StentsPrediction of Restenosis After PCI with Contemporary Drug-Eluting Stents
Prediction of Restenosis After PCI with Contemporary Drug-Eluting Stents
 
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse ModelVascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
Vascular Aging – New Lessons From a Novel "Knock-In" Mouse Model
 
Genetic Insights Into Multiple Sclerosis Pathogenesis
Genetic Insights Into Multiple Sclerosis PathogenesisGenetic Insights Into Multiple Sclerosis Pathogenesis
Genetic Insights Into Multiple Sclerosis Pathogenesis
 
Newer trends in interventional cardiology
Newer trends in interventional cardiologyNewer trends in interventional cardiology
Newer trends in interventional cardiology
 

Viewers also liked

Resume Updated (4)
Resume Updated (4)Resume Updated (4)
Resume Updated (4)
Mahmoud Abdul Azeem
 
6 Ways to Deliver More Engaging Training
6 Ways to Deliver More Engaging Training6 Ways to Deliver More Engaging Training
6 Ways to Deliver More Engaging Training
Human Capital Media
 
Bernardo Rojo Editorial
Bernardo Rojo EditorialBernardo Rojo Editorial
Bernardo Rojo Editorial
Bernardo Rojo
 
Promesse de la famille
Promesse de la famillePromesse de la famille
Promesse de la famille
Leleaderkamanga
 
Le Principe Divin Originel 원리 본체론
Le Principe Divin Originel 원리 본체론Le Principe Divin Originel 원리 본체론
Le Principe Divin Originel 원리 본체론
Leleaderkamanga
 
Message du Monde Spirituel: Anciens Présidents des USA
Message du Monde Spirituel: Anciens Présidents des USA Message du Monde Spirituel: Anciens Présidents des USA
Message du Monde Spirituel: Anciens Présidents des USA
John Gyasuma
 
Les Principes universels et buts dans la vie
Les Principes universels et buts dans la vieLes Principes universels et buts dans la vie
Les Principes universels et buts dans la vie
Leleaderkamanga
 
Inquadramento Diagnostico e Recenti Acquisizioni in tema di Obesità
Inquadramento Diagnostico e Recenti Acquisizioni in tema di ObesitàInquadramento Diagnostico e Recenti Acquisizioni in tema di Obesità
Inquadramento Diagnostico e Recenti Acquisizioni in tema di Obesità
Vincenzo De Geronimo
 
Sudek's Syndrome
Sudek's SyndromeSudek's Syndrome
Sudek's Syndrome
Vincenzo De Geronimo
 
Analisa harga satuan jasa
Analisa harga satuan jasaAnalisa harga satuan jasa
Analisa harga satuan jasa
Ronny wisanggeni
 
4 Amazingly Simple Ways to Reach Moms
4 Amazingly Simple Ways to Reach Moms4 Amazingly Simple Ways to Reach Moms
4 Amazingly Simple Ways to Reach Moms
huddleinc
 

Viewers also liked (12)

Resume Updated (4)
Resume Updated (4)Resume Updated (4)
Resume Updated (4)
 
6 Ways to Deliver More Engaging Training
6 Ways to Deliver More Engaging Training6 Ways to Deliver More Engaging Training
6 Ways to Deliver More Engaging Training
 
Bernardo Rojo Editorial
Bernardo Rojo EditorialBernardo Rojo Editorial
Bernardo Rojo Editorial
 
Promesse de la famille
Promesse de la famillePromesse de la famille
Promesse de la famille
 
Le Principe Divin Originel 원리 본체론
Le Principe Divin Originel 원리 본체론Le Principe Divin Originel 원리 본체론
Le Principe Divin Originel 원리 본체론
 
Message du Monde Spirituel: Anciens Présidents des USA
Message du Monde Spirituel: Anciens Présidents des USA Message du Monde Spirituel: Anciens Présidents des USA
Message du Monde Spirituel: Anciens Présidents des USA
 
Les Principes universels et buts dans la vie
Les Principes universels et buts dans la vieLes Principes universels et buts dans la vie
Les Principes universels et buts dans la vie
 
Inquadramento Diagnostico e Recenti Acquisizioni in tema di Obesità
Inquadramento Diagnostico e Recenti Acquisizioni in tema di ObesitàInquadramento Diagnostico e Recenti Acquisizioni in tema di Obesità
Inquadramento Diagnostico e Recenti Acquisizioni in tema di Obesità
 
Sudek's Syndrome
Sudek's SyndromeSudek's Syndrome
Sudek's Syndrome
 
Analisa harga satuan jasa
Analisa harga satuan jasaAnalisa harga satuan jasa
Analisa harga satuan jasa
 
Sprzedawca
SprzedawcaSprzedawca
Sprzedawca
 
4 Amazingly Simple Ways to Reach Moms
4 Amazingly Simple Ways to Reach Moms4 Amazingly Simple Ways to Reach Moms
4 Amazingly Simple Ways to Reach Moms
 

Similar to 200 is coated stent the answer

Chronic Allograft Injury
Chronic Allograft InjuryChronic Allograft Injury
Chronic Allograft Injury
Malsawmkima Chhakchhuak
 
Year in cardiology - ACS
Year in cardiology - ACSYear in cardiology - ACS
Year in cardiology - ACS
Praveen Nagula
 
InStent Resetenosis: An Algorithmic Approach to Diagnosis and Treatment
InStent Resetenosis:  An Algorithmic Approach to Diagnosis and TreatmentInStent Resetenosis:  An Algorithmic Approach to Diagnosis and Treatment
InStent Resetenosis: An Algorithmic Approach to Diagnosis and Treatment
NAJEEB ULLAH SOFI
 
11. geriatric maxfac trauma(50) Dr. RAHUL TIWARI
11. geriatric maxfac trauma(50) Dr. RAHUL TIWARI11. geriatric maxfac trauma(50) Dr. RAHUL TIWARI
11. geriatric maxfac trauma(50) Dr. RAHUL TIWARI
CLOVE Dental OMNI Hospitals Andhra Hospital
 
Plasmacytoma
PlasmacytomaPlasmacytoma
Plasmacytoma
fondas vakalis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Jeremiah Laichena
 
Acute Lymphoblastic Leukaemia (ALL) in Children
Acute Lymphoblastic Leukaemia (ALL) in ChildrenAcute Lymphoblastic Leukaemia (ALL) in Children
Acute Lymphoblastic Leukaemia (ALL) in Children
spa718
 
5 year follow-up
5 year follow-up5 year follow-up
5 year follow-up
Boris Maizel
 
Chronic OM JC.pdf
Chronic OM JC.pdfChronic OM JC.pdf
Chronic OM JC.pdf
tahaismail2610
 
Biovascular scaffolds - current status 2015
Biovascular scaffolds -  current status 2015Biovascular scaffolds -  current status 2015
Biovascular scaffolds - current status 2015
Anshul Kumar Gupta
 
OGS .pdf
OGS .pdfOGS .pdf
OGS .pdf
60083576Riyan
 
MolMed ASCO Prolonged Survival Times Patients With Acute Leukaemia Treated Wi...
MolMed ASCO Prolonged Survival Times Patients With Acute Leukaemia Treated Wi...MolMed ASCO Prolonged Survival Times Patients With Acute Leukaemia Treated Wi...
MolMed ASCO Prolonged Survival Times Patients With Acute Leukaemia Treated Wi...
social_molmed
 
Can platelet-rich plasma (PRP) improve bone healing? A comparison between the...
Can platelet-rich plasma (PRP) improve bone healing? A comparison between the...Can platelet-rich plasma (PRP) improve bone healing? A comparison between the...
Can platelet-rich plasma (PRP) improve bone healing? A comparison between the...
Angad Malhotra
 
Esnrt poster cd20
Esnrt poster cd20Esnrt poster cd20
Esnrt poster cd20
FarragBahbah
 
The Pathogenesis of Rheumatoid Arthritis.pptx
The Pathogenesis of Rheumatoid Arthritis.pptxThe Pathogenesis of Rheumatoid Arthritis.pptx
The Pathogenesis of Rheumatoid Arthritis.pptx
Juan Diego
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
seayat1103
 
Esnrt poster dental tumour
Esnrt poster dental tumourEsnrt poster dental tumour
Esnrt poster dental tumour
FarragBahbah
 
Orthopaedic infection management dr.saroj
Orthopaedic infection management dr.sarojOrthopaedic infection management dr.saroj
Orthopaedic infection management dr.saroj
sarosem
 
Newer management techniques for glioblastoma
Newer management techniques for glioblastomaNewer management techniques for glioblastoma
Newer management techniques for glioblastoma
abhitux
 
Metastatic Castration Resistant Prostate Cancer(mCRPC)
Metastatic Castration Resistant Prostate Cancer(mCRPC)Metastatic Castration Resistant Prostate Cancer(mCRPC)
Metastatic Castration Resistant Prostate Cancer(mCRPC)
Ashfaq9697931281
 

Similar to 200 is coated stent the answer (20)

Chronic Allograft Injury
Chronic Allograft InjuryChronic Allograft Injury
Chronic Allograft Injury
 
Year in cardiology - ACS
Year in cardiology - ACSYear in cardiology - ACS
Year in cardiology - ACS
 
InStent Resetenosis: An Algorithmic Approach to Diagnosis and Treatment
InStent Resetenosis:  An Algorithmic Approach to Diagnosis and TreatmentInStent Resetenosis:  An Algorithmic Approach to Diagnosis and Treatment
InStent Resetenosis: An Algorithmic Approach to Diagnosis and Treatment
 
11. geriatric maxfac trauma(50) Dr. RAHUL TIWARI
11. geriatric maxfac trauma(50) Dr. RAHUL TIWARI11. geriatric maxfac trauma(50) Dr. RAHUL TIWARI
11. geriatric maxfac trauma(50) Dr. RAHUL TIWARI
 
Plasmacytoma
PlasmacytomaPlasmacytoma
Plasmacytoma
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Acute Lymphoblastic Leukaemia (ALL) in Children
Acute Lymphoblastic Leukaemia (ALL) in ChildrenAcute Lymphoblastic Leukaemia (ALL) in Children
Acute Lymphoblastic Leukaemia (ALL) in Children
 
5 year follow-up
5 year follow-up5 year follow-up
5 year follow-up
 
Chronic OM JC.pdf
Chronic OM JC.pdfChronic OM JC.pdf
Chronic OM JC.pdf
 
Biovascular scaffolds - current status 2015
Biovascular scaffolds -  current status 2015Biovascular scaffolds -  current status 2015
Biovascular scaffolds - current status 2015
 
OGS .pdf
OGS .pdfOGS .pdf
OGS .pdf
 
MolMed ASCO Prolonged Survival Times Patients With Acute Leukaemia Treated Wi...
MolMed ASCO Prolonged Survival Times Patients With Acute Leukaemia Treated Wi...MolMed ASCO Prolonged Survival Times Patients With Acute Leukaemia Treated Wi...
MolMed ASCO Prolonged Survival Times Patients With Acute Leukaemia Treated Wi...
 
Can platelet-rich plasma (PRP) improve bone healing? A comparison between the...
Can platelet-rich plasma (PRP) improve bone healing? A comparison between the...Can platelet-rich plasma (PRP) improve bone healing? A comparison between the...
Can platelet-rich plasma (PRP) improve bone healing? A comparison between the...
 
Esnrt poster cd20
Esnrt poster cd20Esnrt poster cd20
Esnrt poster cd20
 
The Pathogenesis of Rheumatoid Arthritis.pptx
The Pathogenesis of Rheumatoid Arthritis.pptxThe Pathogenesis of Rheumatoid Arthritis.pptx
The Pathogenesis of Rheumatoid Arthritis.pptx
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
 
Esnrt poster dental tumour
Esnrt poster dental tumourEsnrt poster dental tumour
Esnrt poster dental tumour
 
Orthopaedic infection management dr.saroj
Orthopaedic infection management dr.sarojOrthopaedic infection management dr.saroj
Orthopaedic infection management dr.saroj
 
Newer management techniques for glioblastoma
Newer management techniques for glioblastomaNewer management techniques for glioblastoma
Newer management techniques for glioblastoma
 
Metastatic Castration Resistant Prostate Cancer(mCRPC)
Metastatic Castration Resistant Prostate Cancer(mCRPC)Metastatic Castration Resistant Prostate Cancer(mCRPC)
Metastatic Castration Resistant Prostate Cancer(mCRPC)
 

More from Society for Heart Attack Prevention and Eradication

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
Society for Heart Attack Prevention and Eradication
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
Society for Heart Attack Prevention and Eradication
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
Society for Heart Attack Prevention and Eradication
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
Society for Heart Attack Prevention and Eradication
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
Society for Heart Attack Prevention and Eradication
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch2002
Vp watch2002Vp watch2002
Vp symposium31602
Vp symposium31602Vp symposium31602
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vp meeting orlando2003_new template
Vp meeting orlando2003_new templateVp meeting orlando2003_new template
Vp meeting orlando2003_new template
Society for Heart Attack Prevention and Eradication
 
Vpiii lobby-02
Vpiii lobby-02Vpiii lobby-02

More from Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 
Vp meeting orlando2003_new template
Vp meeting orlando2003_new templateVp meeting orlando2003_new template
Vp meeting orlando2003_new template
 
Vpiii lobby-02
Vpiii lobby-02Vpiii lobby-02
Vpiii lobby-02
 

Recently uploaded

Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 

Recently uploaded (20)

Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 

200 is coated stent the answer

  • 1. Editorial Slides - VP Watch, September 5th , 2001, Volume 1, Issue 25 Is coated stent THE answer?
  • 2. In-Stent Restenosis = Neointimal Hyperplasia The long-term clinical efficacy of intracoronary stenting is limited by restenosis which, occurs in 15-30 % of patients. In- stent restenosis is due solely to neointimal hyperplasia. Shape and chemical biocompatibility of stent, and the extent of inflammatory response to stenting are among major factors predicting restenosis. Intravascular radiation has shown significant benefit however the cost, repated interventions, radiation safety, short and long term adverse effect all remain unresolved issues. Experimental data suggest that in-situ immunosuppressant and inhibitors of cell cycle progression may be an effective strategy to prevent restenosis.
  • 3. Effects of drug-coated stents on arterial repair Suzuki et al., Circulation. 2001;104:1188 Endothelium SM C Fibrin 0 1/2 1 1 1/2 2 2 1/2 3 Repairscore Control Dexametasone Sirolimus SRL+DEX From VP Watch this week: High-power photomicrographs of bare metal (B) and SRL-coated (C) stents
  • 4. As highlighted in VP Watch this week, Suzuki, Carter, et al. determined that stents coated with a nonerodable polymer matrix containing 185 µg SRL compared with a bare metal stent reduces restenosis by 50% through inhibiting cellular proliferation. The dose-response effects for this SRL-eluting stent are incompletely characterized but, they indicated a dose- dependent reduction in intimal hyperplasia with 60 µg to 200 µg SRL–coated stents in the rabbit model. Circulation 2001;104:1188  Also Suzuki et al. also showed that stent-based delivery of dexamethasone (DEX) alone is insufficient to inhibit neointimal formation. They did not observed any synergism in combination of dexamethasonwith SRL. Circulation 2001;104:1188
  • 5.  It was shown years go that intraperitoneal administration of SRL, a potent immunosuppressive agent, resulted in a dose-dependent inhibition of arterial intimal thickening caused by either chronic alloimmune or mechanical injury in a rat model. (Gregory CR, Huie P, Billingham ME, et al., Transplantation. 1993; 55: 1409–1418) Other studies about the effect of Sirolimus on restenosis:  Other studies also show that SRL inhibits the proliferation of vascular SMC in human and rat in vitro by blocking the G1 /S transition. (Poon M et al., J Clin Invest. 1996; 98: 2277–2283 and Marx SO et al., Circ Res. 1995; 76: 412– 417)  Study of Gallo et al. indicates that systemic SRL therapy significantly reduces the proliferative response after coronary angioplasty in the porcine model. (Circulation. 1999; 99: 2164–2170)
  • 6. Latest on Sirulimon restenosis clinical trial: The RAVEL study this week reported “zero” restenosis at 210 days. Congress of European Society of Cardiology Stockholm Sep 1-5th
  • 7. Conclusion:  Stent-based delivery of Sirolimus via a nonerodable polymer matrix is feasible and effectively reduces restenosis. Adding dexamethasone did not offer additional benefit. If RAVEL holds true for 5 years, the immunosuppressant RAPAMUNE® (Sirolimus) coated stents becomes the standard therapy for coronary revascularization.
  • 8. Questions: Feel free to send your response to:  Discussion-Group@VulnerablePlaque.org  Knowing atherosclerosis as a diffuse disease, do you think that stenting vulnerable plaques with coated stents can be the treatment of choice besides statins? If the coated stent reduces restenosis by 90%, will you stent every vulnerable plaque? What if you find 3, 4, 5 or more vulnerable plaques in one patient?